Apoptosis of THP-1 macrophages induced by protoporphyrin IX-mediated sonodynamic therapy

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 2239-2246

  Guo, Shuyuan ^a   Sun, Xin ^a,b   Cheng, Jiali ^a   Xu, Haobo ^a   Dan, Juhua ^b   Shen, Jing ^a   Zhou, Qi ^c   Zhang, Yun ^a   Meng, Lingli ^a   Cao, Wenwu ^c,d   Tian, Ye ^a,b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Key Laboratory   (China)

^c HARBIN INSTITUTE OF TECHNOLOGY   (China)

^d PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Atherosclerotic plaque; Cytoskeleton; Macrophage; Protoporphyrin IX; Singlet oxygen; Sonodynamic therapy

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; PROTOPORPHYRIN; REACTIVE OXYGEN METABOLITE; SINGLET OXYGEN;

AMPLIFIER; APOPTOSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; BIOACCUMULATION; CELL DEATH; CELL DISRUPTION; CELL LEVEL; CELL VIABILITY; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPLASM; CYTOSKELETON; CYTOSKELETON DISRUPTION; CYTOTOXICITY; DRUG EFFECT; GENERATOR; HUMAN; HUMAN CELL; MACROPHAGE; SONODYNAMIC THERAPY; TREATMENT DURATION; ULTRASONIC GENERATOR; ULTRASOUND; ULTRASOUND THERAPY; ULTRASOUND TRANSDUCER;

ATHEROSCLEROTIC PLAQUE; CYTOSKELETON; MACROPHAGE; PROTOPORPHYRIN IX; SINGLET OXYGEN; SONODYNAMIC THERAPY;

APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; CYTOSKELETON; HUMANS; MACROPHAGES; NECROSIS; PROTOPORPHYRINS; SINGLET OXYGEN; SONICATION; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84879299469     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S43717     Document Type: Article

References (31)

1. Shibaguchi H, Tsuru H, Kuroki M. Sonodynamic cancer therapy:a non-invasive and repeatable approach using low-intensity ultrasound with a sonosensitizer. Anticancer Res. 2011;31(7):2425-2429.
2. Rosenthal I, Sostaric JZ, Riesz P. Sonodynamic therapy - a review of the synergistic effects of drugs and ultrasound. Ultrason Sonochem. 2004;11(6):349-363.
3. Lv Y, Fang M, Zheng J, et al. Low-intensity ultrasound combined with 5-aminolevulinic acid administration in the treatment of human tongue squamous carcinoma. Cell Physiol Biochem. 2012;30(2): 321-333.
4. Barati AH, Mokhtari-Dizaji M, Mozdarani H, et al. Treatment of murine tumors using dual-frequency ultrasound in an experimental in vivo model. Ultrasound Med Biol. 2009;35(5):756-763.
5. Miyoshi N, Igarashi T, Riesz P. Evidence against singlet oxygen formation by sonolysis of aqueous oxygen-saturated solutions of hematoporphyrin and rose bengal. The mechanism of sonodynamic therapy. Ultrason Sonochem. 2000;7(3):121-124.
6. Umemura S, Yumita N, Nishigaki R, Umemura K. Mechanism of cell damage by ultrasound in combination with hematoporphyrin. Jpn J Cancer Res. 1990;81(9):962-966.
7. Li Y, Wang P, Zhao P, et al. Apoptosis induced by sonodynamic treatment by protoporphyrin IX on MDA-MB-231 cells. Ultrasonics. 2012;52(4):490-496.
8. Gao Q, Wang F, Guo S, et al. Sonodynamic effect of an anti-inflammatory agent - emodin - on macrophages. Ultrasound Med Biol. 2011; 37(9):1478-1485.
9. Song W, Cui H, Zhang R, et al. Apoptosis of SAS cells induced by sonodynamic therapy using 5-aminolevulinic acid sonosensitizer. Anticancer Res. 2011;31(1):39-45.
10. Yumita N, Iwase Y, Nishi K, et al. Sonodynamically-induced antitumor effect of mono-l-aspartyl chlorin e6 (NPe6). Anticancer Res. 2011;31(2):501-506.
11. Arakawa K, Hagisawa K, Kusano H, et al. Sonodynamic therapy decreased neointimal hyperplasia after stenting in the rabbit iliac artery. Circulation. 2002;105(2):149-151.
12. Weber C, Noels H. Atherosclerosis: current pathogenesis and therapeutic options. Nat Med. 2011;17(11):1410-1422.
13. Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell. 2011;145(3):341-355.
14. Tiwari RL, Singh V, Barthwal MK. Macrophages: an elusive yet emerging therapeutic target of atherosclerosis. Med Res Rev. 2008;28(4):483-544.
15. Zhang JX, Zhou JW, Chan CF, et al. Comparative studies of the cellular uptake, subcellular localization, and cytotoxic and phototoxic antitumor properties of ruthenium(II)-porphyrin conjugates with different linkers. Bioconjug Chem. 2012;23(8):1623-1638.
16. Hsiang YN, Crespo MT, Richter AM, et al. In vitro and in vivo uptake of benzoporphyrin derivative into human and miniswine atherosclerotic plaque. Photochem Photobiol. 1993;57(4):670-674.
17. Peng C, Li Y, Liang H, et al. Detection and photodynamic therapy of inflamed atherosclerotic plaques in the carotid artery of rabbits. J Photochem Photobiol B. 2011;102(1):26-31.
18. Luchetti F, Canonico B, Curci R, et al. Melatonin prevents apoptosis induced by UV-B treatment in U937 cell line. J Pineal Res. 2006; 40(2):158-167.
19. Casella JF, Flanagan MD, Lin S. Cytochalasin D inhibits actin polymerization and induces depolymerization of actin filaments formed during platelet shape change. Nature. 1981;293(5830):302-305.
20. Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol. 1993;122(1):103-111.
21. Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011;473(7347):317-325.
22. Ji Z, Yang G, Vasovic V, et al. Subcellular localization pattern of protoporphyrin IX is an important determinant for its photodynamic efficiency of human carcinoma and normal cell lines. J Photochem Photobiol B. 2006;84(3):213-220.
23. Liu Q, Hamblin MR. Macrophage-targeted photodynamic therapy: scavenger receptor expression and activation state. Int J Immunopathol Pharmacol. 2005;18(3):391-402.
24. Martinet W, Verheye S, De Meyer GR. Selective depletion of macrophages in atherosclerotic plaques via macrophage-specific initiation of cell death. Trends Cardiovasc Med. 2007;17(2):69-75.
25. Tabas I. Macrophage death and defective inflammation resolution in atherosclerosis. Nat Rev Immunol. 2010;10(1):36-46.
26. Agostinis P, Berg K, Cengel KA, et al. Photodynamic therapy of cancer: an update. CA Cancer J Clin. 2011;61(4):250-281.
27. Mates JM. Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology. Toxicology. 2000;153(1-3):83-104.
28. Marushige Y, Marushige K. Alterations in focal adhesion and cytoskeletal proteins during apoptosis. Anticancer Res. 1998;18(1A):301-307.
29. Zhao X, Liu Q, Tang W, et al. Damage effects of protoporphyrin IX - sonodynamic therapy on the cytoskeletal F-actin of Ehrlich ascites carcinoma cells. Ultrason Sonochem. 2009;16(1):50-56.
30. Croons V, Martinet W, De Meyer GR. Selective removal of macrophages in atherosclerotic plaques as a pharmacological approach for plaque stabilization: benefits versus potential complications. Curr Vasc Pharmacol. 2010;8(4):495-508.
31. De Meyer I, Martinet W, De Meyer GR. Therapeutic strategies to deplete macrophages in atherosclerotic plaques. Br J Clin Pharmacol. 2012;74(2):246-263.